Huron Announces Record Second Quarter 2023 Financial Results and Increases 2023 Guidance
SECOND QUARTER 2023 HIGHLIGHTS
- Total revenues increased
$73.4 million , or 26.9%, to$346.8 million in Q2 2023 from$273.3 million in Q2 2022. - Net income increased
$10.8 million , or 78.1%, to$24.7 million in Q2 2023 from$13.9 million in Q2 2022. - Adjusted EBITDA(6), a non-GAAP measure, increased
$15.3 million , or 46.0%, to$48.5 million in Q2 2023 from$33.2 million in Q2 2022. - Diluted earnings per share increased
$0.61 , or 92.4%, to$1.27 in Q2 2023 from$0.66 in Q2 2022. - Adjusted diluted earnings per share(6), a non-GAAP measure, increased
$0.55 , or 66.3%, to$1.38 in Q2 2023 from$0.83 in Q2 2022. - Net cash provided by operating activities was
$78.2 million in Q2 2023, compared to$28.9 million in Q2 2022.
YEAR-TO-DATE 2023 HIGHLIGHTS
- Total revenues increased
$131.3 million , or 24.6%, to$664.7 million for the first six months of 2023 from$533.4 million for the same prior year period. - Revenues within the Digital capability increased 23.5% to
$290.2 million for the first six months of 2023, compared to$234.9 million for the same prior year period. - Net income was
$38.1 million for the first six months of 2023, compared to$40.7 million for the same prior year period. Results for the first six months of 2022 included a non-recurring, unrealized gain of$19.8 million , net of tax, related to the company's investment in a hospital-at-home company. - Adjusted EBITDA(6), a non-GAAP measure, increased
$22.7 million , or 40.9%, to$78.0 million for the first six months of 2023 from$55.3 million for the same prior year period. - Adjusted EBITDA as a percentage of revenues(6), a non-GAAP measure, increased 130 basis points to 11.7% for the first six months of 2023 from 10.4% for the same prior year period.
- Diluted earnings per share increased to
$1.95 for the first six months of 2023, compared to$1.94 for the same prior year period which included the non-recurring, unrealized gain related to the company's investment in a hospital-at-home company. - Adjusted diluted earnings per share(6), a non-GAAP measure, increased
$0.93 , or 70.5%, to$2.25 for the first six months of 2023 from$1.32 for the same prior year period. - Huron returned
$59.6 million to shareholders in the first six months of 2023 by repurchasing 0.8 million shares of the company's common stock.
2023 GUIDANCE
- Huron increases its previous full year 2023 revenue and earnings guidance ranges, including revenue expectations in a range of
$1.30 billion to$1.34 billion .
“We continue to drive strong organic growth in each of our three operating segments while expanding our companywide operating margin, consistent with our strategy. Revenues grew 27% over the prior year quarter, reflective of continued demand for our Consulting and Managed Services and Digital capabilities,” said
“Our updated annual guidance reflects our outlook for strong growth in 2023. We are pleased that our performance over the past six quarters has outpaced our 2022 investor day financial objectives, and we remain confident in our ability to deliver at or above those goals in the years ahead,” added Hussey.
SECOND QUARTER 2023 RESULTS
Revenues increased
Net income increased
Second quarter 2023 earnings before interest, taxes, depreciation and amortization ("EBITDA")(6) increased
In addition to using EBITDA to evaluate the company’s financial performance, management uses other non-GAAP financial measures, which exclude the effect of the following items (in thousands):
|
|
Three Months Ended |
||||||
|
|
2023 |
|
2022 |
||||
|
Amortization of intangible assets |
$ |
1,974 |
|
|
$ |
2,818 |
|
|
Restructuring charges |
$ |
1,699 |
|
|
$ |
2,069 |
|
|
Other losses (gains) |
$ |
(623 |
) |
|
$ |
21 |
|
|
Tax effect of adjustments |
$ |
(808 |
) |
|
$ |
(1,301 |
) |
|
Foreign currency transaction losses (gains), net |
$ |
288 |
|
|
$ |
(100 |
) |
Adjusted EBITDA(6) increased
The number of revenue-generating professionals(1) increased 21.9% to 5,174 as of
YEAR-TO-DATE 2023 RESULTS
Revenues increased
Net income was
EBITDA(6) for the first six months of 2023 was
In addition to using EBITDA to evaluate the company’s financial performance, management uses other non-GAAP financial measures, which exclude the effect of the following items (in thousands):
|
|
Six Months Ended |
||||||
|
|
2023 |
|
2022 |
||||
|
Amortization of intangible assets |
$ |
4,205 |
|
|
$ |
5,678 |
|
|
Restructuring charges |
$ |
3,983 |
|
|
$ |
3,624 |
|
|
Other losses (gains) |
$ |
(188 |
) |
|
$ |
33 |
|
|
Transaction-related expenses |
$ |
— |
|
|
$ |
50 |
|
|
Unrealized gain on preferred stock investment |
$ |
— |
|
|
$ |
(26,964 |
) |
|
Tax effect of adjustments |
$ |
(2,120 |
) |
|
$ |
4,658 |
|
|
Foreign currency transaction losses (gains), net |
$ |
368 |
|
|
$ |
(81 |
) |
Adjusted EBITDA(6) increased
The number of revenue-generating professionals(1) increased 21.9% to 5,174 as of
Additionally, in the first six months of 2023, Huron repurchased 826,542 shares of the company's common stock for
OPERATING INDUSTRIES
The company’s year-to-date 2023 revenues by operating segment as a percentage of total company revenues are as follows: Healthcare (49%); Education (32%); and Commercial (19%). Financial results by operating industry are included in the attached schedules and in Huron's forthcoming Quarterly Report on Form 10-Q filing for the quarter ended
OUTLOOK FOR 2023
Based on currently available information, the company increased guidance for full year 2023 revenues before reimbursable expenses to a range of
SECOND QUARTER 2023 WEBCAST
The company will host a webcast to discuss its financial results today,
USE OF NON-GAAP FINANCIAL MEASURES(6)
In evaluating the company’s financial performance and outlook, management uses EBITDA, adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income, and adjusted diluted earnings per share, which are non-GAAP measures. Management uses these non-GAAP financial measures to gain an understanding of the company's comparative operating performance (when comparing such results with previous periods or forecasts). These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect the company's ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing their business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. Management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in
Management has provided its outlook regarding adjusted EBITDA and adjusted diluted earnings per share, both of which are non-GAAP financial measures and exclude certain charges. Management has not reconciled these non-GAAP financial measures to the corresponding GAAP financial measures because guidance for the various reconciling items is not provided. Management is unable to provide guidance for these reconciling items because they cannot determine their probable significance, as certain items are outside of the company's control and cannot be reasonably predicted since these items could vary significantly from period to period. Accordingly, reconciliations to the corresponding GAAP financial measures are not available without unreasonable effort.
ABOUT HURON
Huron is a global professional services firm that collaborates with clients to put possible into practice by creating sound strategies, optimizing operations, accelerating digital transformation, and empowering businesses and their people to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve. Learn more at www.huronconsultinggroup.com.
Statements in this press release that are not historical in nature, including those concerning the company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “goals,” “guidance,” or “outlook” or similar expressions. These forward-looking statements reflect the company's current expectations about future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: failure to achieve expected utilization rates, billing rates, and the necessary number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under “Item 1A. Risk Factors” in Huron's Annual Report on Form 10-K for the year ended
|
|
|||||||||||||||
|
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) |
|||||||||||||||
|
(In thousands, except per share amounts) |
|||||||||||||||
|
(Unaudited) |
|||||||||||||||
|
|
|||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
Revenues and reimbursable expenses: |
|
|
|
|
|
|
|
||||||||
|
Revenues |
$ |
346,759 |
|
|
$ |
273,325 |
|
|
$ |
664,654 |
|
|
$ |
533,374 |
|
|
Reimbursable expenses |
|
8,140 |
|
|
|
7,492 |
|
|
|
16,630 |
|
|
|
12,218 |
|
|
Total revenues and reimbursable expenses |
|
354,899 |
|
|
|
280,817 |
|
|
|
681,284 |
|
|
|
545,592 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
||||||||
|
Direct costs (exclusive of depreciation and amortization included below) |
|
235,198 |
|
|
|
189,233 |
|
|
|
463,581 |
|
|
|
376,480 |
|
|
Reimbursable expenses |
|
8,121 |
|
|
|
7,576 |
|
|
|
16,745 |
|
|
|
12,332 |
|
|
Selling, general and administrative expenses |
|
64,019 |
|
|
|
46,033 |
|
|
|
126,308 |
|
|
|
94,428 |
|
|
Restructuring charges |
|
1,699 |
|
|
|
2,069 |
|
|
|
3,983 |
|
|
|
3,624 |
|
|
Depreciation and amortization |
|
6,143 |
|
|
|
6,902 |
|
|
|
12,517 |
|
|
|
13,766 |
|
|
Total operating expenses |
|
315,180 |
|
|
|
251,813 |
|
|
|
623,134 |
|
|
|
500,630 |
|
|
Operating income |
|
39,719 |
|
|
|
29,004 |
|
|
|
58,150 |
|
|
|
44,962 |
|
|
Other income (expense), net: |
|
|
|
|
|
|
|
||||||||
|
Interest expense, net of interest income |
|
(5,796 |
) |
|
|
(2,446 |
) |
|
|
(10,099 |
) |
|
|
(4,642 |
) |
|
Other income (expense), net |
|
1,062 |
|
|
|
(4,881 |
) |
|
|
2,781 |
|
|
|
19,484 |
|
|
Total other income (expense), net |
|
(4,734 |
) |
|
|
(7,327 |
) |
|
|
(7,318 |
) |
|
|
14,842 |
|
|
Income before taxes |
|
34,985 |
|
|
|
21,677 |
|
|
|
50,832 |
|
|
|
59,804 |
|
|
Income tax expense |
|
10,273 |
|
|
|
7,802 |
|
|
|
12,701 |
|
|
|
19,077 |
|
|
Net income |
$ |
24,712 |
|
|
$ |
13,875 |
|
|
$ |
38,131 |
|
|
$ |
40,727 |
|
|
Earnings per share: |
|
|
|
|
|
|
|
||||||||
|
Net income per basic share |
$ |
1.30 |
|
|
$ |
0.67 |
|
|
$ |
2.00 |
|
|
$ |
1.97 |
|
|
Net income per diluted share |
$ |
1.27 |
|
|
$ |
0.66 |
|
|
$ |
1.95 |
|
|
$ |
1.94 |
|
|
Weighted average shares used in calculating earnings per share: |
|
|
|
|
|
|
|
||||||||
|
Basic |
|
18,939 |
|
|
|
20,582 |
|
|
|
19,029 |
|
|
|
20,715 |
|
|
Diluted |
|
19,486 |
|
|
|
20,967 |
|
|
|
19,598 |
|
|
|
21,047 |
|
|
Comprehensive income (loss): |
|
|
|
|
|
|
|
||||||||
|
Net income |
$ |
24,712 |
|
|
$ |
13,875 |
|
|
$ |
38,131 |
|
|
$ |
40,727 |
|
|
Foreign currency translation adjustments, net of tax |
|
327 |
|
|
|
(656 |
) |
|
|
379 |
|
|
|
(699 |
) |
|
Unrealized gain (loss) on investment, net of tax |
|
553 |
|
|
|
773 |
|
|
|
4,426 |
|
|
|
(1,888 |
) |
|
Unrealized gain on cash flow hedging instruments, net of tax |
|
2,463 |
|
|
|
971 |
|
|
|
134 |
|
|
|
5,296 |
|
|
Other comprehensive income |
|
3,343 |
|
|
|
1,088 |
|
|
|
4,939 |
|
|
|
2,709 |
|
|
Comprehensive income |
$ |
28,055 |
|
|
$ |
14,963 |
|
|
$ |
43,070 |
|
|
$ |
43,436 |
|
|
|
|||||||
|
CONSOLIDATED BALANCE SHEETS |
|||||||
|
(In thousands, except share and per share amounts) |
|||||||
|
(Unaudited) |
|||||||
|
|
|||||||
|
|
|
|
|
||||
|
Assets |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
16,583 |
|
|
$ |
11,834 |
|
|
Receivables from clients, net |
|
152,300 |
|
|
|
147,852 |
|
|
Unbilled services, net |
|
174,409 |
|
|
|
141,781 |
|
|
Income tax receivable |
|
6,475 |
|
|
|
960 |
|
|
Prepaid expenses and other current assets |
|
29,734 |
|
|
|
26,057 |
|
|
Total current assets |
|
379,501 |
|
|
|
328,484 |
|
|
Property and equipment, net |
|
23,440 |
|
|
|
26,107 |
|
|
Deferred income taxes, net |
|
1,397 |
|
|
|
1,554 |
|
|
Long-term investments |
|
97,227 |
|
|
|
91,194 |
|
|
Operating lease right-of-use assets |
|
27,829 |
|
|
|
30,304 |
|
|
Other non-current assets |
|
83,777 |
|
|
|
73,039 |
|
|
Intangible assets, net |
|
19,188 |
|
|
|
23,392 |
|
|
|
|
624,966 |
|
|
|
624,966 |
|
|
Total assets |
$ |
1,257,325 |
|
|
$ |
1,199,040 |
|
|
Liabilities and stockholders’ equity |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
$ |
9,720 |
|
|
$ |
14,254 |
|
|
Accrued expenses and other current liabilities |
|
27,472 |
|
|
|
27,268 |
|
|
Accrued payroll and related benefits |
|
126,430 |
|
|
|
171,723 |
|
|
Current maturities of operating lease liabilities |
|
11,208 |
|
|
|
10,530 |
|
|
Deferred revenues |
|
24,703 |
|
|
|
21,909 |
|
|
Total current liabilities |
|
199,533 |
|
|
|
245,684 |
|
|
Non-current liabilities: |
|
|
|
||||
|
Deferred compensation and other liabilities |
|
34,363 |
|
|
|
33,614 |
|
|
Long-term debt |
|
395,000 |
|
|
|
290,000 |
|
|
Operating lease liabilities, net of current portion |
|
41,407 |
|
|
|
45,556 |
|
|
Deferred income taxes, net |
|
35,404 |
|
|
|
32,146 |
|
|
Total non-current liabilities |
|
506,174 |
|
|
|
401,316 |
|
|
Commitments and contingencies |
|
|
|
||||
|
Stockholders’ equity |
|
|
|
||||
|
Common stock; |
|
218 |
|
|
|
223 |
|
|
|
|
(141,407 |
) |
|
|
(137,556 |
) |
|
Additional paid-in capital |
|
279,070 |
|
|
|
318,706 |
|
|
Retained earnings |
|
390,679 |
|
|
|
352,548 |
|
|
Accumulated other comprehensive income |
|
23,058 |
|
|
|
18,119 |
|
|
Total stockholders’ equity |
|
551,618 |
|
|
|
552,040 |
|
|
Total liabilities and stockholders’ equity |
$ |
1,257,325 |
|
|
$ |
1,199,040 |
|
|
|
|||||||
|
CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
(In thousands) |
|||||||
|
(Unaudited) |
|||||||
|
|
|||||||
|
|
Six Months Ended |
||||||
|
|
|
2023 |
|
|
|
2022 |
|
|
Cash flows from operating activities: |
|
|
|
||||
|
Net income |
$ |
38,131 |
|
|
$ |
40,727 |
|
|
Adjustments to reconcile net income to cash flows from operating activities: |
|
|
|
||||
|
Depreciation and amortization |
|
12,549 |
|
|
|
13,766 |
|
|
Non-cash lease expense |
|
3,340 |
|
|
|
3,174 |
|
|
Lease-related impairment charge |
|
2,086 |
|
|
|
— |
|
|
Share-based compensation |
|
23,151 |
|
|
|
15,166 |
|
|
Amortization of debt discount and issuance costs |
|
382 |
|
|
|
397 |
|
|
Allowances for doubtful accounts |
|
53 |
|
|
|
47 |
|
|
Deferred income taxes |
|
1,755 |
|
|
|
7,089 |
|
|
(Gain) loss on sale of property and equipment, excluding transaction costs |
|
1 |
|
|
|
(1,117 |
) |
|
Change in fair value of contingent consideration liabilities |
|
(233 |
) |
|
|
33 |
|
|
Change in fair value of preferred stock investment |
|
— |
|
|
|
(26,964 |
) |
|
Changes in operating assets and liabilities, net of acquisitions and divestiture: |
|
|
|
||||
|
(Increase) decrease in receivables from clients, net |
|
(4,440 |
) |
|
|
(28,825 |
) |
|
(Increase) decrease in unbilled services, net |
|
(32,567 |
) |
|
|
(28,329 |
) |
|
(Increase) decrease in current income tax receivable / payable, net |
|
(6,141 |
) |
|
|
9,394 |
|
|
(Increase) decrease in other assets |
|
(4,880 |
) |
|
|
3,984 |
|
|
Increase (decrease) in accounts payable and other liabilities |
|
(5,594 |
) |
|
|
(13,524 |
) |
|
Increase (decrease) in accrued payroll and related benefits |
|
(44,277 |
) |
|
|
(43,420 |
) |
|
Increase (decrease) in deferred revenues |
|
2,804 |
|
|
|
(1,834 |
) |
|
Net cash used in operating activities |
|
(13,880 |
) |
|
|
(50,236 |
) |
|
Cash flows from investing activities: |
|
|
|
||||
|
Purchases of property and equipment |
|
(3,725 |
) |
|
|
(6,800 |
) |
|
Investment in life insurance policies |
|
(2,188 |
) |
|
|
— |
|
|
Distributions from life insurance policies |
|
2,956 |
|
|
|
— |
|
|
Purchases of businesses |
|
38 |
|
|
|
(1,948 |
) |
|
Capitalization of internally developed software costs |
|
(12,998 |
) |
|
|
(3,974 |
) |
|
Proceeds from note receivable |
|
154 |
|
|
|
157 |
|
|
Proceeds from sale of property and equipment |
|
— |
|
|
|
4,750 |
|
|
Divestiture of business |
|
— |
|
|
|
207 |
|
|
Net cash used in investing activities |
|
(15,763 |
) |
|
|
(7,608 |
) |
|
Cash flows from financing activities: |
|
|
|
||||
|
Proceeds from exercise of stock options |
|
987 |
|
|
|
1,185 |
|
|
Shares redeemed for employee tax withholdings |
|
(9,728 |
) |
|
|
(7,011 |
) |
|
Share repurchases |
|
(60,368 |
) |
|
|
(52,443 |
) |
|
Proceeds from bank borrowings |
|
230,000 |
|
|
|
224,000 |
|
|
Repayments of bank borrowings |
|
(125,000 |
) |
|
|
(114,780 |
) |
|
Payments for debt issuance costs |
|
(58 |
) |
|
|
— |
|
|
Deferred payments on business acquisition |
|
(1,500 |
) |
|
|
(1,875 |
) |
|
Net cash provided by financing activities |
|
34,333 |
|
|
|
49,076 |
|
|
Effect of exchange rate changes on cash |
|
59 |
|
|
|
(55 |
) |
|
Net increase (decrease) in cash and cash equivalents |
|
4,749 |
|
|
|
(8,823 |
) |
|
Cash and cash equivalents at beginning of the period |
|
11,834 |
|
|
|
20,781 |
|
|
Cash and cash equivalents at end of the period |
$ |
16,583 |
|
|
$ |
11,958 |
|
|
|
||||||||||||||||||||||
|
SEGMENT OPERATING RESULTS AND OTHER OPERATING DATA |
||||||||||||||||||||||
|
(Unaudited) |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
|
Three Months Ended |
|
Percent Increase (Decrease) |
|
Six Months Ended |
|
Percent Increase (Decrease) |
||||||||||||||
|
Segment and Consolidated Operating Results (in thousands): |
|
|
2023 |
|
|
|
2022 |
|
|
|
|
2023 |
|
|
|
2022 |
|
|
||||
|
Healthcare: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Revenues |
|
$ |
173,768 |
|
|
$ |
128,474 |
|
|
35.3 |
% |
|
$ |
322,817 |
|
|
$ |
250,350 |
|
|
28.9 |
% |
|
Operating income |
|
$ |
49,151 |
|
|
$ |
30,364 |
|
|
61.9 |
% |
|
$ |
81,406 |
|
|
$ |
58,396 |
|
|
39.4 |
% |
|
Segment operating margin |
|
|
28.3 |
% |
|
|
23.6 |
% |
|
|
|
|
25.2 |
% |
|
|
23.3 |
% |
|
|
||
|
Education: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Revenues |
|
$ |
110,694 |
|
|
$ |
88,225 |
|
|
25.5 |
% |
|
$ |
214,841 |
|
|
$ |
168,887 |
|
|
27.2 |
% |
|
Operating income |
|
$ |
27,397 |
|
|
$ |
21,691 |
|
|
26.3 |
% |
|
$ |
50,562 |
|
|
$ |
35,997 |
|
|
40.5 |
% |
|
Segment operating margin |
|
|
24.8 |
% |
|
|
24.6 |
% |
|
|
|
|
23.5 |
% |
|
|
21.3 |
% |
|
|
||
|
Commercial: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Revenues |
|
$ |
62,297 |
|
|
$ |
56,626 |
|
|
10.0 |
% |
|
$ |
126,996 |
|
|
$ |
114,137 |
|
|
11.3 |
% |
|
Operating income |
|
$ |
10,472 |
|
|
$ |
11,915 |
|
|
(12.1 |
)% |
|
$ |
24,539 |
|
|
$ |
24,129 |
|
|
1.7 |
% |
|
Segment operating margin |
|
|
16.8 |
% |
|
|
21.0 |
% |
|
|
|
|
19.3 |
% |
|
|
21.1 |
% |
|
|
||
|
Total Huron: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Revenues |
|
$ |
346,759 |
|
|
$ |
273,325 |
|
|
26.9 |
% |
|
$ |
664,654 |
|
|
$ |
533,374 |
|
|
24.6 |
% |
|
Reimbursable expenses |
|
|
8,140 |
|
|
|
7,492 |
|
|
8.6 |
% |
|
|
16,630 |
|
|
|
12,218 |
|
|
36.1 |
% |
|
Total revenues and reimbursable expenses |
|
$ |
354,899 |
|
|
$ |
280,817 |
|
|
26.4 |
% |
|
$ |
681,284 |
|
|
$ |
545,592 |
|
|
24.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Segment operating income |
|
$ |
87,020 |
|
|
$ |
63,970 |
|
|
36.0 |
% |
|
$ |
156,507 |
|
|
$ |
118,522 |
|
|
32.0 |
% |
|
Items not allocated at the segment level: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Other operating expenses |
|
|
42,923 |
|
|
|
29,912 |
|
|
43.5 |
% |
|
|
89,263 |
|
|
|
63,460 |
|
|
40.7 |
% |
|
Depreciation and amortization |
|
|
4,378 |
|
|
|
5,054 |
|
|
(13.4 |
)% |
|
|
9,094 |
|
|
|
10,100 |
|
|
(10.0 |
)% |
|
Total operating income |
|
|
39,719 |
|
|
|
29,004 |
|
|
36.9 |
% |
|
|
58,150 |
|
|
|
44,962 |
|
|
29.3 |
% |
|
Other income (expense), net |
|
|
(4,734 |
) |
|
|
(7,327 |
) |
|
(35.4 |
)% |
|
|
(7,318 |
) |
|
|
14,842 |
|
|
N/M |
|
|
Income before taxes |
|
$ |
34,985 |
|
|
$ |
21,677 |
|
|
61.4 |
% |
|
$ |
50,832 |
|
|
$ |
59,804 |
|
|
(15.0 |
)% |
|
Other Operating Data: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Number of revenue-generating professionals by segment (at period end) (1): |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Healthcare |
|
|
2,059 |
|
|
|
1,619 |
|
|
27.2 |
% |
|
|
2,059 |
|
|
|
1,619 |
|
|
27.2 |
% |
|
Education |
|
|
1,701 |
|
|
|
1,407 |
|
|
20.9 |
% |
|
|
1,701 |
|
|
|
1,407 |
|
|
20.9 |
% |
|
Commercial (2) |
|
|
1,414 |
|
|
|
1,217 |
|
|
16.2 |
% |
|
|
1,414 |
|
|
|
1,217 |
|
|
16.2 |
% |
|
Total |
|
|
5,174 |
|
|
|
4,243 |
|
|
21.9 |
% |
|
|
5,174 |
|
|
|
4,243 |
|
|
21.9 |
% |
|
Revenue by capability: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Consulting and Managed Services (3) |
|
$ |
197,255 |
|
|
$ |
147,871 |
|
|
33.4 |
% |
|
$ |
374,449 |
|
|
$ |
298,455 |
|
|
25.5 |
% |
|
Digital |
|
|
149,504 |
|
|
|
125,454 |
|
|
19.2 |
% |
|
|
290,205 |
|
|
|
234,919 |
|
|
23.5 |
% |
|
Total |
|
$ |
346,759 |
|
|
$ |
273,325 |
|
|
26.9 |
% |
|
$ |
664,654 |
|
|
$ |
533,374 |
|
|
24.6 |
% |
|
Number of revenue-generating professionals by capability (at period end)(1): |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Consulting and Managed Services (4) |
|
|
2,473 |
|
|
|
2,018 |
|
|
22.5 |
% |
|
|
2,473 |
|
|
|
2,018 |
|
|
22.5 |
% |
|
Digital |
|
|
2,701 |
|
|
|
2,225 |
|
|
21.4 |
% |
|
|
2,701 |
|
|
|
2,225 |
|
|
21.4 |
% |
|
Total |
|
|
5,174 |
|
|
|
4,243 |
|
|
21.9 |
% |
|
|
5,174 |
|
|
|
4,243 |
|
|
21.9 |
% |
|
Utilization rate by capability (5): |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Consulting |
|
|
76.0 |
% |
|
|
73.2 |
% |
|
|
|
|
76.1 |
% |
|
|
72.4 |
% |
|
|
||
|
Digital |
|
|
74.7 |
% |
|
|
74.3 |
% |
|
|
|
|
72.8 |
% |
|
|
73.6 |
% |
|
|
||
|
(1) |
Consists of our full-time consultants who generate revenues based on the number of hours worked; full-time equivalents, which consists of coaches and their support staff within the Culture and Organizational excellence solution, consultants who work variable schedules as needed by clients, and full-time employees who provide software support and maintenance services to clients; and our Healthcare Managed Services employees who provide revenue cycle billing, collections insurance verification and change integrity services to clients. |
|
|
(2) |
The majority of our revenue-generating professionals within our Commercial segment can provide services across all of our industries, including healthcare and education. |
|
|
(3) |
Managed Services capability revenues within our Healthcare segment was |
|
|
|
Managed Services capability revenues within our Education segment was |
|
|
(4) |
The number of Managed Services revenue-generating professionals within our Healthcare segment as of |
|
|
|
The number of Managed Services revenue-generating professionals within our Education segment as of |
|
|
(5) |
Utilization rate is calculated by dividing the number of hours our billable consultants worked on client assignments during a period by the total available working hours for these billable consultants during the same period. Available hours are determined by the standard hours worked by each billable consultant, adjusted for part-time hours, and |
|
|
|||||||||||||||
|
RECONCILIATION OF NET INCOME |
|||||||||||||||
|
TO ADJUSTED EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION AND AMORTIZATION (6) |
|||||||||||||||
|
(In thousands) |
|||||||||||||||
|
(Unaudited) |
|||||||||||||||
|
|
|||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
Revenues |
$ |
346,759 |
|
|
$ |
273,325 |
|
|
$ |
664,654 |
|
|
$ |
533,374 |
|
|
Net income |
$ |
24,712 |
|
|
$ |
13,875 |
|
|
$ |
38,131 |
|
|
$ |
40,727 |
|
|
Add back: |
|
|
|
|
|
|
|
||||||||
|
Income tax expense |
|
10,273 |
|
|
|
7,802 |
|
|
|
12,701 |
|
|
|
19,077 |
|
|
Interest expense, net of interest income |
|
5,796 |
|
|
|
2,446 |
|
|
|
10,099 |
|
|
|
4,642 |
|
|
Depreciation and amortization |
|
6,330 |
|
|
|
7,097 |
|
|
|
12,883 |
|
|
|
14,219 |
|
|
Earnings before interest, taxes, depreciation and amortization (EBITDA) (6) |
|
47,111 |
|
|
|
31,220 |
|
|
|
73,814 |
|
|
|
78,665 |
|
|
Add back: |
|
|
|
|
|
|
|
||||||||
|
Restructuring charges |
|
1,699 |
|
|
|
2,069 |
|
|
|
3,983 |
|
|
|
3,624 |
|
|
Other losses (gains) |
|
(623 |
) |
|
|
21 |
|
|
|
(188 |
) |
|
|
33 |
|
|
Transaction-related expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
50 |
|
|
Unrealized gain on preferred stock investment |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(26,964 |
) |
|
Foreign currency transaction losses (gains), net |
|
288 |
|
|
|
(100 |
) |
|
|
368 |
|
|
|
(81 |
) |
|
Adjusted EBITDA (6) |
$ |
48,475 |
|
|
$ |
33,210 |
|
|
$ |
77,977 |
|
|
$ |
55,327 |
|
|
Adjusted EBITDA as a percentage of revenues (6) |
|
14.0 |
% |
|
|
12.2 |
% |
|
|
11.7 |
% |
|
|
10.4 |
% |
|
|
|||||||||||||||
|
RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME (6) |
|||||||||||||||
|
(In thousands, except per share amounts) |
|||||||||||||||
|
(Unaudited) |
|||||||||||||||
|
|
|||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
Net income |
$ |
24,712 |
|
|
$ |
13,875 |
|
|
$ |
38,131 |
|
|
$ |
40,727 |
|
|
Weighted average shares - diluted |
|
19,486 |
|
|
|
20,967 |
|
|
|
19,598 |
|
|
|
21,047 |
|
|
Diluted earnings per share |
$ |
1.27 |
|
|
$ |
0.66 |
|
|
$ |
1.95 |
|
|
$ |
1.94 |
|
|
Add back: |
|
|
|
|
|
|
|
||||||||
|
Amortization of intangible assets |
|
1,974 |
|
|
|
2,818 |
|
|
|
4,205 |
|
|
|
5,678 |
|
|
Restructuring charges |
|
1,699 |
|
|
|
2,069 |
|
|
|
3,983 |
|
|
|
3,624 |
|
|
Other losses (gains) |
|
(623 |
) |
|
|
21 |
|
|
|
(188 |
) |
|
|
33 |
|
|
Transaction-related expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
50 |
|
|
Unrealized gain on preferred stock investment |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(26,964 |
) |
|
Tax effect of adjustments |
|
(808 |
) |
|
|
(1,301 |
) |
|
|
(2,120 |
) |
|
|
4,658 |
|
|
Total adjustments, net of tax |
|
2,242 |
|
|
|
3,607 |
|
|
|
5,880 |
|
|
|
(12,921 |
) |
|
Adjusted net income (6) |
$ |
26,954 |
|
|
$ |
17,482 |
|
|
$ |
44,011 |
|
|
$ |
27,806 |
|
|
Adjusted weighted average shares - diluted |
|
19,486 |
|
|
|
20,967 |
|
|
|
19,598 |
|
|
|
21,047 |
|
|
Adjusted diluted earnings per share (6) |
$ |
1.38 |
|
|
$ |
0.83 |
|
|
$ |
2.25 |
|
|
$ |
1.32 |
|
|
(6) |
In evaluating the company’s financial performance and outlook, management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income, and adjusted diluted earnings per share, which are non-GAAP measures. Management uses these non-GAAP financial measures to gain an understanding of the company's comparative operating performance (when comparing such results with previous periods or forecasts). These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect the company's ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing the company's business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. Management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230727411171/en/
MEDIA CONTACT
abovis@hcg.com
INVESTOR CONTACT
investor@hcg.com
Source: Huron